Calmodulin in Dispersed Human Parathyroid Cells*
- 1 November 1981
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 53 (5) , 1064-1071
- https://doi.org/10.1210/jcem-53-5-1064
Abstract
We investigated the presence and several of the properties of calmodulin in human parathyroid cells. Boiled extracts of such cell preparations contained a heat-stable factor causing a 2- to 3-fold calcium-dependent stimulation of calmodulin- deficient phosphodiesterase activity, which was parallel to that due to pure porcine calmodulin. This activation could be totally blocked by 10−4 M trifluoperazine, with half-maximal inhibition at 3 × 10−5 M, similar to the effects of this phenothiazine on porcine calmodulin. These results suggested the presence of calmodulin in human parathyroid cells. By comparison with known quantities of porcine calmodulin, human parathyroid cells contained 9–208 ng calmodulin/106 cells. The content of calmodulin in 3 normal parathyroid glands [65 ± 8 (±SEM) ng/106 cells] did not differ significantly from that of 12 adenomas (61 ± 16 ng/106 cells). Cells from 7 glands showing secondary hyperplasia, however, had significantly greater levels of calmodulin (164 ± 11 ng/106 cells) than either normal cells or adenomas (P < 0.001 and P < 0.005, respectively). Extracts of human parathyroid cells caused half-maximal stimulation of phosphodiesterase activity at 1.1–4.8 JUM free calcium. The concentrations of calcium half-maximally activating phosphodiesterase (Ka) did not differ significantly for normal or abnormal cells (3.3 ± 0.03 vs. 2.6 ± 0.33; P > 0.3). Moreover, in 2 cases in which normal parathyroid tissue was obtained from patients with adenomas, the Ka values for calcium for the normal and abnormal cellswere similar (3.3 vs. 2.5 and 3.4 vs. 2.5 µM, respectively). Finally, there was no significant correlation between either the content of calmodulin or the Ka for calcium and the set-point for calcium [the calcium concentration causing half-maximal inhibition of parathyroid hormone (PTH) release] or the maximal rate of PTH secretion for dispersed parathyroid cells. These results suggest that human parathyroid cells contain calmodulin, but provide no evidence for a role of this protein in the abnormal calcium-regulated PTH release in hyperparathyroidism.Keywords
This publication has 19 references indexed in Scilit:
- Calcium-regulated parathyroid hormone release in primary hyperparathyroidismThe American Journal of Medicine, 1979
- Relationship of Intracellular 3′,5′-Adenosine Monophosphate Accumulation to Parathyroid Hormone Release from Dispersed Bovine Parathyroid Cells*Endocrinology, 1978
- Responsiveness of neoplastic and hyperplastic parathyroid tissues to calcium in vitro.Journal of Clinical Investigation, 1978
- Inhibition of Ca2+-activated cyclic nucleotide phosphodiesterase reaction by a heat-stable inhibitor protein from bovine brain.Journal of Biological Chemistry, 1978
- Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to sepharoseBiochemistry, 1978
- Physicochemical properties of rat testis Ca2+-dependent regulator protein of cyclic nucleotide phosphodiesterase. Relationship of Ca2+-binding, conformational changes, and phosphodiesterase activityJournal of Biological Chemistry, 1977
- Effects of Calcium Ionophores on the Synthesis and Release of Parathyroid HormoneEndocrinology, 1977
- Secretion of Parathyroid Hormone by Abnormal Human Parathyroid Glands in Vitro*Journal of Clinical Endocrinology & Metabolism, 1977
- Preparation of Viable Isolated Bovine Parathyroid CellsEndocrinology, 1976
- Assay errors of cyclic 3′,5′-nucleotide phosphodiesterase activity based on the recovery of adenosine alone using an anionic-exchange resin columnAnalytical Biochemistry, 1976